2025 annual financial data
Veraxa Biotech 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -42,270.69%.
Operating income was -66,216,575 CHF and net income was -66,613,990 CHF.
Operating cash flow was -9,902,331 CHF.
Get free Veraxa Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 23,426 CHF
- Operating income
- -66,216,575 CHF
- Net income
- -66,613,990 CHF
- Operating cash flow
- -9,902,331 CHF